19 May 2022
Amolyt Pharma has announced its accepted abstracts that will be presented at the European Congress of Endocrinology (ECE 2022) and the Endocrine Society Meeting (ENDO 2022). The selection covers new data on treatments for rare endocrine diseases, including acromegaly and parathyroid disorders.
Study links premature ovarian insufficiency (POI) to risk of mortality
17 May 2024
Cardiovascular disease mortality associated with low testosterone in men
17 May 2024
People with obesity using semaglutide see cardiovascular improvements
17 May 2024
Men with obesity lose more weight with cash incentives, research says
17 May 2024
Research Assistant in Endocrinology (University of Sheffield)
14 May 2024